Stoboclo 60 mg/mL
denosumab-bmwo · INJECTION · CELLTRION USA, Inc.
No Recall History
Plain English
Stoboclo is a injection containing denosumab-bmwo at 60 mg/mL, taken subcutaneous. Manufactured by CELLTRION USA, Inc..
Key Facts
- Brand Name
- Stoboclo
- Generic Name
- denosumab-bmwo
- NDC Code (Product)
72606-037- Manufacturer
- CELLTRION USA, Inc.
- Strength
- 60 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761404
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 07/02/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Stoboclo used for?
Stoboclo contains denosumab-bmwo. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Stoboclo a controlled substance?
Stoboclo is not classified as a controlled substance by the DEA.
What is the generic name for Stoboclo?
The generic name for Stoboclo is denosumab-bmwo. There are 3 other brand versions of denosumab-bmwo.
What is the NDC code for Stoboclo 60 mg/mL?
The NDC (National Drug Code) for Stoboclo 60 mg/mL is 72606-037, listed by CELLTRION USA, Inc..